Research progress of acute idiopathic maculopathy
10.3980/j.issn.1672-5123.2024.11.09
- VernacularTitle:急性特发性黄斑病变研究进展
- Author:
Yiran JIA
1
;
Libin JIANG
1
;
Chaoyang WANG
1
;
Chunli CHEN
1
Author Information
1. Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
- Publication Type:Journal Article
- Keywords:
acute idiopathic maculopathy;
multimodal imaging features;
differential diagnosis;
pathogenesis;
treatment
- From:
International Eye Science
2024;24(11):1738-1742
- CountryChina
- Language:Chinese
-
Abstract:
Acute idiopathic maculopathy(AIM)is an inflammatory lesion of unknown cause that primarily affects the macula. It follows a unique natural course, distinct from other maculopathy, often manifesting as a sudden loss of visual acuity followed by flu-like symptoms that gradually resolve as the disease subsides. A comprehensive understanding of the unique history, multimodal imaging, and a thorough systematic examination are crucial in determining the final diagnosis of AIM. The treatment and prognosis of AIM remain controversial. Meanwhile, it presents similar clinical manifestations and pathological changes to various chorioretinopathy, posing challenges for clinical differentiation. This article provides a review of its pathogenesis, clinical symptoms, multimodal imaging features, diagnosis and differential diagnosis, treatment and prognosis, in order to reduce misdiagnosis and mistreatment while enhancing comprehension of AIM.
